Page 2411 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 2411
2151.e2 Part XII Hemostasis and Thrombosis
42. Stone GW, McLaurin BT, Cox DA, et al: Bivalirudin for patients with 45. Faxon DP, Eikelboom JW, Berger PB, et al: Antithrombotic therapy in
acute coronary syndromes. N Engl J Med 355:2203, 2006. patients with atrial fibrillation undergoing coronary stenting: a North
43. Cavender MA, Sabatine MS: Bivalirudin versus heparin in patients American perspective: executive summary. Circ Cardiovasc Interv 4:522,
planned for percutaneous coronary intervention: a meta-analysis of 2011.
randomised controlled trials. Lancet 384(9943):599–606, 2014. 46. Connolly SJ, Ezekowitz MD, Yusuf S, et al: Dabigatran versus warfarin
44. Andreotti F, Testa L, Biondi-Zoccai GG, et al: Aspirin plus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139, 2009.
compared with aspirin alone after acute coronary syndromes: an updated 47. Granger CB, Alexander JH, McMurray JJ, et al: Apixaban versus warfarin
and comprehensive meta-analysis of 25,307 patients. Eur Heart J 27:519, in patients with atrial fibrillation. N Engl J Med 365:981, 2011.
2006.
